High-dose RT and chemotherapy in metastatic NPC
Published
08 October 2012
| Article by American Journal of Clinical Oncology 2012
| Tags:
radiation-therapy,
nasopharyngeal-carcinoma,
outcomes,
metastatic
High-dose RT and chemotherapy in metastatic NPC
Nasopharyngeal carcinoma (NPC) is the most commonly diagnosed head and neck cancer in Southeast Asia. Most NPC patients present with nonmetastatic disease; however, 6% of cases are metastatic at initial diagnosis. The most common regions for distant metastasis in NPC include bone, lung, and liver. Although...
To read the full article, please register for GetInsideHealth below.
Register for GetInsideHealth
GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.
Please fill in the form below to register.
Already Registered?
Please login using
form at top of page
Fields with an asterisk (*) are mandatory
About you
Login information
Newsletter
Additional information